Chir-98014 ct98014
WebDescription: CHIR98024, also known as CT-98024, is a potent GSK3 Inhibitor with IC50=1 nM. CHIR98024 is an isomer of CHIR98014, both of which structure are very similar. Many vendors confused each other. Chemical Structure CHIR98024 CAS# 556813-39-9 (CHIR98024) Instruction Theoretical Analysis MedKoo Cat#: 556003 Name: CHIR98024 WebCHIR 98014 is a potent and reversible inhibitor of Glycogen Synthase Kinase 3 (GSK3), inhibiting both the alpha (IC50: 0.65 nM) and beta (IC50: 0.58 nM) isoforms. GSK3 …
Chir-98014 ct98014
Did you know?
WebCHIR98014, also known as CT-98014, is a reversible, cell-permeable inhibitor of GSK3α and GSK3β (IC50 = 0.65 and 0.58 nM, respectively). It is inactive against a series of other serine/threonine or tyrosine kinases. WebCHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC50 values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000-fold selectivity for GSK-3 versus 20 other protein kinases tested, including closest homologs Cdc2 and ERK2. references
Web目录号：S2745 别名: CT98014. 仅限科研使用. CHIR-98014 (CT98014)是一种有效的 GSK-3α/β 抑制剂，无细胞试验中 IC50 为0.65 nM/0.58 nM，作用于GSK-3比作用于其最密切的 … Web3.根据权利要求1所述的组合物，其特征在于:糖原合成酶激酶3抑制剂选自CHIR-99021、TWS119、SB216763、CHIR-98014、Tideglusib、SB415286、LY2090314、AZD1080、3F8、L308、NSC693868、Kenpaulone, TCG24、TCS2002、FRATide, Indirubin-3’ -oxime、ARA-A014418、B10、MeB1。
WebCHIR-98014 is a selective GSK3 inhibitor; potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
WebOct 1, 2008 · Chronic inhibition of GSK-3 in human muscle cells using CT98014 and CHIR 98023 stimulated glucose transport to a level comparable to that observed with either lithium or insulin [ 40 ]. The effects of GSK-3 inhibition on glucose uptake in diabetic models has also been assessed.
WebCHIR-98014 is a potent, selective and ATP-competitive inhibitor of GSK3α and GSK3β (IC₅₀ = 0.65 and 0.58 nM, respectively). In addition, CHIR-98014 displays 500 to greater than … chronic fatigue syndrome potsWebCHIR-98014. Catalog No. T2608 CAS 252935-94-7. Synonyms: CT98014, CHIR 98014, CHIR98014. CHIR-98014 is a selective GSK3 inhibitor; potentiate insulin activation of … chronic fatigue syndrome physical therapyWebIn vitro (25°C) DMSO: Warmed: 7 mg/mL (14.39 mM) Water: Insoluble: Ethanol: Insoluble: In vivo: 5% DMSO+corn oil: 1 mg/mL *<1 mg/ml means slightly soluble or insoluble. *Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values.This is normal and is due to slight batch-to-batch … chronic fatigue syndrome service leedsWeb2024中学生弘扬民族精神演讲稿中学生弘扬民族精神演讲稿演讲稿的格式由称谓开场白主干结尾等几部分组成.在发展不断提速的社会中,我们都可能会用到演讲稿,如何写一份恰当的演讲稿呢下面是我为大家整理的中学生弘扬民族精神演讲稿,仅供参考,希望能够帮,文库 … chronic fatigue syndrome refhelpWebCHIR-98014 (CT98014) is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2. BIO chronic fatigue syndrome remediesWebCHIR-98014 is a potent, selective and ATP-competitive inhibitor of GSK3α and GSK3β (IC₅₀ = 0.65 and 0.58 nM, respectively). In addition, CHIR-98014 displays 500 to greater than … chronic fatigue syndrome va rating scaleWebAug 1, 2024 · A significant reduction in cell viability was observed after treatment with 1 μM of CHIR 98014 and BIO for 72 h. e BrdU assay of 10 μM BIO and CHIR 98014-treated H1975 cells demonstrated ... chronic fatigue syndrome treatment new mexico